PHASE 1 CLINICAL TRIALS UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: EVALUATION OF THERAPEUTICS FOR TUBERCULOSIS
$222,661N01FY2017AINIH
Dynport Vaccine Company, Llc, Frederick MD
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
View original record on NIH RePORTER →